Isocoumarins as estrogen receptor beta selective ligands: Isomers of isoflavone phytoestrogens and their metabolites.
暂无分享,去创建一个
Fabio Stossi | F. Stossi | B. Katzenellenbogen | J. Katzenellenbogen | M. De Angelis | Meri De Angelis | Benita S Katzenellenbogen | John A Katzenellenbogen | M. Waibel | Michael Waibel
[1] J. Gustafsson,et al. Update on estrogen signaling , 2003, FEBS letters.
[2] Fabio Stossi,et al. Indazole estrogens: highly selective ligands for the estrogen receptor beta. , 2005, Journal of medicinal chemistry.
[3] Li‐Ping Sun,et al. Chemistry of aminophenols. Part 1: Remarkable additive effect on Sonogashira cross-coupling of 2-carboxamidoaryl triflates and application to novel synthesis of indoles , 2001 .
[4] J. Polman,et al. ERβ: Identification and characterization of a novel human estrogen receptor , 1996 .
[5] B. Katzenellenbogen,et al. Molecular basis for the subtype discrimination of the estrogen receptor-beta-selective ligand, diarylpropionitrile. , 2003, Molecular endocrinology.
[6] G. C. Fu,et al. Pd/P(t-Bu)(3): a mild and general catalyst for Stille reactions of aryl chlorides and aryl bromides. , 2002, Journal of the American Chemical Society.
[7] G. Firestone,et al. Estrogen Receptor β Inhibits Human Breast Cancer Cell Proliferation and Tumor Formation by Causing a G2 Cell Cycle Arrest , 2004, Cancer Research.
[8] Qing‐Yun Chen. TRIFLUOROMETHYLATION OF ORGANIC HALIDES WITH DIFLUOROCARBENE PRECURSORS , 1995 .
[9] B. Katzenellenbogen,et al. Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[10] K. Zamani,et al. Total synthesis of homalicine and its related dihydro aglycon , 2000 .
[11] B. Katzenellenbogen,et al. Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. , 1996, Molecular endocrinology.
[12] B. Katzenellenbogen,et al. Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. , 2001, Journal of medicinal chemistry.
[13] E. Napolitano,et al. Influence of alkoxyalkyl substituents in the regioselective lithiation of the benzene ring , 1983 .
[14] R. Karas,et al. The protective effects of estrogen on the cardiovascular system. , 2002, The New England journal of medicine.
[15] R. Gandour,et al. The identity of 4-bromo-3-phenylisocoumarin. A facile preparation by bromolactonization of alkyl 2-(2-phenylethynyl)benzoates , 1984 .
[16] M Carlquist,et al. Structure of the ligand‐binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist , 1999, The EMBO journal.
[17] K E Carlson,et al. Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: evidence that an open pocket conformation is required for ligand interaction. , 1997, Biochemistry.
[18] R. Larock,et al. Synthesis of Isocoumarins and α-Pyrones via Electrophilic Cyclization , 2003 .
[19] R. Rossi,et al. New procedures for the selective synthesis of 2(2H)-pyranone derivatives and 3-aryl-4-iodoisocoumarins , 2002 .
[20] R. Grubbs,et al. Safe and Convenient Procedure for Solvent Purification , 1996 .
[21] B. Katzenellenbogen,et al. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. , 2004, Bioorganic & medicinal chemistry.
[22] J. Gustafsson,et al. Cloning of a novel receptor expressed in rat prostate and ovary. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[23] B. Komm,et al. Evaluation of an Estrogen Receptor-β Agonist in Animal Models of Human Disease , 2003 .
[24] L. Mannina,et al. Synthesis of 3-arylisocoumarins, including thunberginols A and B, unsymmetrical 3,4-disubstituted isocoumarins, and 3-ylidenephthalides via iodolactonization of methyl 2-ynylbenzoates or the corresponding carboxylic acids , 2003 .
[25] Eric S Manas,et al. Structure-based design of estrogen receptor-beta selective ligands. , 2004, Journal of the American Chemical Society.
[26] C. Behl. Oestrogen as a neuroprotective hormone , 2002, Nature Reviews Neuroscience.